iSpecimen Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-18.
0001213900-26-058050
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-14.
0001213900-26-090226
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 8 previous paragraphs and 8 current paragraphs.
7 unchanged; 1 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Reworded paragraphs (1)
Previous wording
There have been no material changes with respect to risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 1, 2026.
Current wording
There have been no material changes with respect to risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 1, 2026, except that investors should consider the following developments that occurred during the period covered by this Quarterly Report: (i) the Company’s revenue declined approximately 83% for the six months ended June 30, 2026 compared to the prior-year period; (ii) the Company effected a second reverse stock split at a ratio of 1-for-40 in April 2026 to regain or maintain compliance with Nasdaq’s minimum bid price requirement; (iii) the Company’s sales and marketing expenses increased approximately 245% for the six months ended June 30, 2026 compared to the prior-year period, primarily driven by advertising and promotion costs, while revenue continued to decline; and (iv) management has concluded that substantial doubt exists regarding the Company’s ability to continue as a going concern, and management’s plans to mitigate such doubt cannot be considered probable. These developments may amplify the risks described in the Company’s Annual Report on Form 10-K.